Fidia anuncia la designación de fármaco huérfano de la FDA para ONCOFID®-P ...Middle East

-Fidia anuncia la designación de fármaco huérfano de la FDA para ONCOFID®-P para el tratamiento del mesotelioma maligno, el cáncer causado por la exposición al amianto - ONCOFID®-P es una innovadora conjugación del fármaco anticanceroso paclitaxel (taxol) con ácido hialurónico (AH). -...

Hence then, the article about fidia anuncia la designacion de farmaco huerfano de la fda para oncofid p was published today ( Wednesday 04/08/2021 - 04:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fidia anuncia la designación de fármaco huérfano de la FDA para ONCOFID®-P )

Also on site :

• Watch Rome Seymour Deliver First Message to Lyric's Famous Dad After 'Big Brother 28' Eviction: 'I Am Sorry' (Exclusive)
• ‘Wouldn’t It Be Fun If There Were a Coachella for Broadway?’ Now There Is 
• Teen girl who died after being found unresponsive in hot tub in NW Indiana identified